EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia

Karthik Nath iD, Jasme Lee, Theresa A Elko, Lauren Levy, Elaina Preston, Sean M Devlin, Doris M Ponce, Richard J Lin, Brian C Shaffer, Christina Cho, Ioannis Politikos, Ann A Jakubowski und 10 weitere

American Journal of Hematology · 2023

DOI: 10.1002/ajh.27084 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift American Journal of Hematology, 2023. Verfasst von Karthik Nath und 21 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute, Graft vs Host Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allogeneic hematopoietic cell transplantation (allo‐HCT) is a potentially curative treatment for patients with acute leukemia. Despite this, studies have shown that only a minority of patients ultimately proceed to allo‐HCT. The primary objective of this prospective, observational study was to identify the rate of allo‐HCT in patients for whom it was recommended, and reasons why patients deemed appropriate and eligible for HCT did not subsequently undergo transplant. Between April 2016 and April 2021, adult patients with newly diagnosed or relapsed/refractory acute leukemia were enrolled at the time of induction/reinduction therapy. Initial transplantation workup and allo‐HCT recommendations were made during the early phase of induction/reinduction. Of the 307 enrolled patients, allo‐HCT was recommended to 85% ( n = 259), of whom 66% ( n = 170) underwent transplant. Donor sources comprised 54% human leukocyte antigen (HLA)‐matched unrelated donors, 20% HLA‐matched sibling donors and HLA‐mismatched graft sources with 15% umbilical cord blood units, 8% HLA‐mismatched unrelated donors, and 4% HLA‐haploidentical donors. The most common reason for transplant disqualification in the 89 patients in whom it was initially recommended was persistent/relapsed disease (70%), followed by early patient death (10%). In this prospective study, we report a high allo‐HCT rate, which may be due to early transplant referral and workup. The main allo‐HCT barrier was disease control, followed by early patient death. With the increasing availability of HLA‐mismatched graft sources, the lack of donor availability was not a transplant barrier. Further development of novel transplant strategies for patients not achieving remission and improvements in induction regimens could result in increased allo‐HCT utilization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteGraft vs Host DiseaseAdultHumansProspective StudiesUnrelated DonorsTransplantation, HomologousAcute DiseaseHLA AntigensRetrospective Studies

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Karthik Nath

Förderung

  • NCI NIH HHS

Zitieren

APA

Nath, K., Lee, J., Elko, T. A., Levy, L., Preston, E., Devlin, S. M., Ponce, D. M., Lin, R. J., Shaffer, B. C., Cho, C., Politikos, I., Jakubowski, A. A., Park, J. H., Rampal, R., Perales, M. A., Tallman, M. S., Barker, J. N., Berman, E., Tamari, R., …, & Gyurkocza, B. (2023). Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia. American Journal of Hematology. https://doi.org/10.1002/ajh.27084

Vancouver

Nath K, Lee J, Elko TA, Levy L, Preston E, Devlin SM, et al. Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia. American Journal of Hematology. 2023. doi:10.1002/ajh.27084

BibTeX
@article{Nath2023,
  author = {Nath, Karthik and Lee, Jasme and Elko, Theresa A and Levy, Lauren and Preston, Elaina and Devlin, Sean M and Ponce, Doris M and Lin, Richard J and Shaffer, Brian C and Cho, Christina and Politikos, Ioannis and Jakubowski, Ann A and Park, Jae H and Rampal, Raajit and Perales, Miguel-Angel and Tallman, Martin S and Barker, Juliet N and Berman, Ellin and Tamari, Roni and Stein, Eytan and Giralt, Sergio A and Gyurkocza, Boglarka},
  title = {Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia},
  journal = {American Journal of Hematology},
  year = {2023},
  doi = {10.1002/ajh.27084}
}
Kostenlos starten →